Few & Far Between: How Biotech Gets Built

Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.


Listen Later

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

...more
View all episodesView all episodes
Download on the App Store

Few & Far Between: How Biotech Gets BuiltBy Chris O'Brien

  • 5
  • 5
  • 5
  • 5
  • 5

5

15 ratings